Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

NCT04513717 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2753

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Stage III Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8

Interventions

DRUG: Apalutamide
DRUG: Bicalutamide
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
DRUG: Buserelin
PROCEDURE: Computed Tomography
DRUG: Degarelix
DRUG: Flutamide
DRUG: Goserelin
DRUG: Histrelin
DRUG: Leuprolide
PROCEDURE: Magnetic Resonance Elastography
PROCEDURE: Positron Emission Tomography
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
DRUG: Relugolix
DRUG: Triptorelin

Sponsor

NRG Oncology

Collaborators

[object Object]